Medical Intl Tech (MDLH) Fair Value & Analysis
Healthcare · US · Market cap $8.4K
Medical Intl Tech
MDLH · US
Fair value as of: Aug 13, 2026
From 9 valuation models · updated 4 days ago
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from $0.0001 (bear) to $0.0001 (bull), base $0.0001. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 54/100 (solid quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range $0.0001 – $0.0300 · the $0.0001 price screens below the $0.0001 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Medical Intl Tech (MDLH) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Trailing-twelve-month revenue stands at $398K. Revenue declined 63.9% year over year. Fundamentals as of Aug 13, 2026
The share trades near its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at 0%, MDLH screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: DCF Models ($0.0001) versus DCF Models ($0.0001). Highest evidence: Growth DCF (80).
Notify me when MDLH reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 55 · Market factors (momentum, volatility) 56
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Medical International Technology, Inc. produces, markets, and sells needle-free jet injector products for use in humans and animals.
Full company description
Medical International Technology, Inc. produces, markets, and sells needle-free jet injector products for use in humans and animals. It offers Med-Jet model needle-free injection systems for medical, cosmetic dermatology, and mesotherapy applications, as well as for single and mass vaccination in humans; Agro-Jet and Avian-Jet needle-free injection systems for small farm animal, pets clinic use, and livestock vaccination; Avian-Jet needle-free injectors for poultry vaccination; and MINI-JET for day old chick vaccination. The company sells its products to doctors, dentists, nurses, veterinarians, farmers, and home users in approximately 30 countries, including the United States. Medical International Technology, Inc. is based in Montreal, Canada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2012 – FY2015 · reported fiscal years
Medical Intl Tech reported revenue of $545K in FY2015 versus $996K in FY2012, a compound −18.2%/yr. Reported net income was −$61.1K in FY2015.
Watch MDLH: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 204 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $401.27 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €164.40 | €68.55 | -58% |
| Medline Inc MDLN | $35.50 | $30.15 | -15% |
| Becton, Dickinson and Company BDX | $181.41 | $100.46 | -45% |
| Alcon Inc ALC | $73.58 | $39.78 | -46% |
| ResMed Inc RMD | $226.00 | $187.89 | -17% |
| West Pharmaceutical Services, Inc WST | $352.29 | $141.58 | -60% |
| Sartorius Stedim Biotech S.A DIM | €180.30 | €48.88 | -73% |
| Coloplast A/S COLOB | kr 429.70 | kr 382.22 | -11% |
| Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 | ¥77.48 | ¥27.22 | -65% |
Compare Medical Intl Tech with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Medical Intl Tech (MDLH) overvalued or undervalued?
What is the fair value of MDLH?
What is the quality score of MDLH?
What is the revenue of Medical Intl Tech (MDLH)?
What is the net profit margin of MDLH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Medical Intl Tech and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.